Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.
2.

Controlling prescription drug expenditures: a report of success.

Miller DP, Furberg CD, Small RH, Millman FM, Ambrosius WT, Harshbarger JS, Ohl CA.

Am J Manag Care. 2007 Aug;13(8):473-80.

3.

Effect of a three-tier prescription copay on pharmaceutical and other medical utilization.

Motheral B, Fairman KA.

Med Care. 2001 Dec;39(12):1293-304.

PMID:
11717571
4.
5.

Effects of a consumer driven health plan on pharmaceutical spending and utilization.

Parente ST, Feldman R, Chen S.

Health Serv Res. 2008 Oct;43(5 Pt 1):1542-56. doi: 10.1111/j.1475-6773.2008.00857.x. Epub 2008 May 13.

6.
7.

The effect of a closed formulary on prescription drug use and costs.

Motheral BR, Henderson R.

Inquiry. 1999-00 Winter;36(4):481-91.

PMID:
10711322
8.
9.

Nondialysis (home) medication utilization and cost in diabetic and nondiabetic hemodialysis patients.

Manley HJ, Cannella CA.

Nephrol News Issues. 2005 Jan;19(2):27-8, 33-4, 36-8.

PMID:
15717572
10.
11.

Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.

Klepser DG, Huether JR, Handke LJ, Williams CE.

J Manag Care Pharm. 2007 Nov-Dec;13(9):765-77.

12.

The effects of expanded mental health benefits on treatment costs.

Sasso AT, Lurie IZ, Lee JU, Lindrooth RC.

J Ment Health Policy Econ. 2006 Mar;9(1):25-33.

PMID:
16733269
13.

Evaluation of the effect of a consumer-driven health plan on medical care expenditures and utilization.

Parente ST, Feldman R, Christianson JB.

Health Serv Res. 2004 Aug;39(4 Pt 2):1189-210.

14.

Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Muriel AC, Frank RG.

Arch Gen Psychiatry. 2005 Apr;62(4):435-41.

15.

Managing drug costs: the perception of managed care pharmacy directors.

Litton LM, Sisk FA, Akins ME.

Am J Manag Care. 2000 Jul;6(7):805-14.

16.

Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit.

Rodin HA, Heaton AH, Wilson AR, Garrett NA, Plocher DW.

Am J Manag Care. 2009 Dec;15(12):881-8.

17.

Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.

Hartung DM, Carlson MJ, Kraemer DF, Haxby DG, Ketchum KL, Greenlick MR.

Med Care. 2008 Jun;46(6):565-72. doi: 10.1097/MLR.0b013e3181734a77.

PMID:
18520310
18.

The effect of incentive-based formularies on prescription-drug utilization and spending.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG.

N Engl J Med. 2003 Dec 4;349(23):2224-32.

20.

Perspective. Senior drug use unique, needs management, analysts say.

[No authors listed]

Med Health. 2001 Aug 6;55(30):7-8. No abstract available.

PMID:
11507947

Supplemental Content

Support Center